Literature DB >> 9328473

Recurrent mutations in a single exon encoding the evolutionarily conserved olfactomedin-homology domain of TIGR in familial open-angle glaucoma.

M F Adam1, A Belmouden, P Binisti, A P Brézin, F Valtot, A Béchetoille, J C Dascotte, B Copin, L Gomez, A Chaventré, J F Bach, H J Garchon.   

Abstract

Primary open-angle glaucoma (POAG) is a highly prevalent cause of irreversible blindness which associates cupping of the optic disc and alteration of the visual field, elevation of intraocular pressure being a major risk factor. Provided diagnosis is made at an early stage, treatments are available to prevent visual impairment. A locus, GLC1A, has been mapped on chromosome 1q23-q25 in several families affected with juvenile-onset POAG (JOAG) and also in some families affected with juvenile and middle-age onset POAG. Recently, three mutations of the TIGR (Trabecular meshwork-Induced Glucocorticoid Response) gene were shown to be responsible for the disease in several American families and in unrelated POAG patients. We now describe five new mutations in eight French families. All mutations known to date appear to concentrate in the evolutionarily conserved C-terminal domain of TIGR which bears homology to frog olfactomedin, an extracellular matrix glycoprotein of the olfactory epithelium, to rat and human neuronal olfactomedin-related proteins and to F11C3.2, a protein from Caenorhabditis elegans . Moreover, this conserved domain of TIGR is encoded by a single exon to which mutation screening could be limited. Surprisingly, the TIGR message, which is abundantly transcribed in the trabecular meshwork and also in the ciliary body and the sclera, is not expressed in the optic nerve whose degeneration is, however, the primary lesion of POAG.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9328473     DOI: 10.1093/hmg/6.12.2091

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  95 in total

1.  Substratum compliance regulates human trabecular meshwork cell behaviors and response to latrunculin B.

Authors:  Joshua A Wood; Clayton T McKee; Sara M Thomasy; Marion E Fischer; Nihar M Shah; Christopher J Murphy; Paul Russell
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-12-02       Impact factor: 4.799

2.  Interaction of myocilin with gamma-synuclein affects its secretion and aggregation.

Authors:  Irina Surgucheva; Bum-Chan Park; Beatrice Y J T Yue; Stanislav Tomarev; Andrei Surguchov
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

3.  Aggregated myocilin induces russell bodies and causes apoptosis: implications for the pathogenesis of myocilin-caused primary open-angle glaucoma.

Authors:  Gary Hin-Fai Yam; Katarina Gaplovska-Kysela; Christian Zuber; Jürgen Roth
Journal:  Am J Pathol       Date:  2007-01       Impact factor: 4.307

4.  Glucose-regulated protein 94 triage of mutant myocilin through endoplasmic reticulum-associated degradation subverts a more efficient autophagic clearance mechanism.

Authors:  Amirthaa Suntharalingam; Jose F Abisambra; John C O'Leary; John Koren; Bo Zhang; Myung Kuk Joe; Laura J Blair; Shannon E Hill; Umesh K Jinwal; Matthew Cockman; Adam S Duerfeldt; Stanislav Tomarev; Brian S J Blagg; Raquel L Lieberman; Chad A Dickey
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

5.  Targeted Disruption of the Myocilin Gene (Myoc) Suggests that Human Glaucoma-Causing Mutations Are Gain of Function.

Authors:  B S Kim; O V Savinova; M V Reedy; J Martin; Y Lun; L Gan; R S Smith; S I Tomarev; S W John; R L Johnson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

6.  Deletion in the N-terminal half of olfactomedin 1 modifies its interaction with synaptic proteins and causes brain dystrophy and abnormal behavior in mice.

Authors:  Naoki Nakaya; Afia Sultana; Jeeva Munasinghe; Aiwu Cheng; Mark P Mattson; Stanislav I Tomarev
Journal:  Exp Neurol       Date:  2013-10-02       Impact factor: 5.330

7.  Regulation of myocilin-associated exosome release from human trabecular meshwork cells.

Authors:  Emely A Hoffman; Kristin M Perkumas; Lindsey M Highstrom; W Daniel Stamer
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-10-24       Impact factor: 4.799

8.  Low prevalence of MYOC mutations in UK primary open-angle glaucoma patients limits the utility of genetic testing.

Authors:  Micheala A Aldred; Laura Baumber; Alison Hill; Edward C Schwalbe; Kai Goh; Wojciech Karwatowski; Richard C Trembath
Journal:  Hum Genet       Date:  2004-08-25       Impact factor: 4.132

Review 9.  Prospects for genetic intervention in primary open-angle glaucoma.

Authors:  M K Wirtz; T S Acott; J R Samples; J C Morrison
Journal:  Drugs Aging       Date:  1998-11       Impact factor: 3.923

10.  Differential effects of myocilin and optineurin, two glaucoma genes, on neurite outgrowth.

Authors:  Takahisa Koga; Xiang Shen; Jeong-Seok Park; Ye Qiu; Bum-Chan Park; Rajalekshmy Shyam; Beatrice Y J T Yue
Journal:  Am J Pathol       Date:  2009-12-03       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.